An example: trastuzumab (Herceptin®)

Trastuzumab (commercial name Herceptin®) is probably the best studied targeted breast cancer therapy.

Trastuzumab is a monoclonal antibody specific for (anti) HER2.

HER2 - short for “human epidermal growth factor receptor 2”, is a marker for a type of breast cancers - for more information see .

Once activated by molecules present in the blood or tissues, HER2 stimulates cellular growth and multiplication.

Breast tumors with overexpression of HER2 (called HER2 positives or HER+ breast cancers) tend to be very aggressive because their cells are over-stimulated to divide. They are also at high risk of recurrence (when the cancer comes back after being treated) and have low survival rates.

About 15-20% of all breast cancers are HER2+, which is suitable for treatment with trastuzumab.

Trastuzumab was initially approved for the treatments of metastatic cancer – cancer that had already spread–, but is now also used to treat, together with chemotherapy, women with primary HER2+ breast cancers .

Trastuzumab acts by blocking it HER2 from interacting with other molecules and inhibiting cancer proliferation/growth.

Because it is an antibody it can also activate the immune system, further contributing to the destruction of the tumor cells. 

next close
Know… the leaflets on the side effects of breast cancer therapies: how to manage problems, such as nausea and vomiting, or hair loss. (see)
Know… the interactive "familial history", allows the construction of a graphic with the history of breast cancer in your family. (see)
Know… more about cancer biology: what is a mutation and what promotes these changes in cells DNA? (see)
Know… What is a triple negative cancer? Drinking alcohol increases the risk of breast cancer? What is the anatomy of the breast? (see)
Know… what you know about familial breast cancer: complete our 7-question "expert " quiz. (see)
Know… more about sporadic breast cancer, and test your knowledge using our 7-question quiz. (see)
Know… the particularities of breast cancer in man: test your knowledge in our 7-question quiz (see)